Nathalie Lebeurrier

Cytokines in neuroinflammation and Alzheimer's disease.

Denis Vivien, Mathias Cacquevel, D. Vivien, 2004, Current drug targets.

Anti-Mullerian-hormone-dependent regulation of the brain serine-protease inhibitor neuroserpin

P. Sonderegger, C. Ali, D. Vivien, 2008, Journal of Cell Science.

Tissue‐type plasminogen activator rescues neurones from serum deprivation‐induced apoptosis through a mechanism independent of its proteolytic activity

Karim Benchenane, G. Liot, C. Ali, 2006, Journal of neurochemistry.

The brain-specific tissue-type plasminogen activator inhibitor, neuroserpin, protects neurons against excitotoxicity both in vitro and in vivo

P. Sonderegger, G. Liot, C. Ali, 2005, Molecular and Cellular Neuroscience.

The complexity of tissue-type plasminogen activator: can serine protease inhibitors help in stroke management?

C. Ali, D. Vivien, N. Lebeurrier, 2004, Expert opinion on therapeutic targets.

Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis

Y. Itoyama, A. Bar-Or, J. Antel, 2018, Journal of Neuroinflammation.

HtrA1-dependent proteolysis of TGF-β controls both neuronal maturation and developmental survival

L. Dauphinot, M. Ehrmann, A. Baldi, 2008, Cell Death and Differentiation.

Sp1 and Smad transcription factors co-operate to mediate TGF-β-dependent activation of amyloid-β precursor protein gene transcription

E. Mackenzie, C. Gabriel, D. Vivien, 2004 .